Form 4: Savers Value Village COO Jubran N. Tanious Executes Option Exercises and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Jubran N. Tanious, President & COO of Savers Value Village, Inc., exercised stock options and sold 20,000 shares of common stock on April 1, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On April 1, 2024, Jubran N. Tanious, the President & COO of Savers Value Village, Inc. (SVV), executed transactions involving the company's common stock.
- Tanious exercised options to acquire 20,000 shares of common stock at an exercise price of $1.41 per share.
- Simultaneously, Tanious sold 20,000 shares of common stock at a weighted average price of $19.1292 per share, with prices ranging from $18.875 to $19.32.
- The sale was conducted under a 10b5-1 trading plan adopted on September 15, 2023.
- Following these transactions, Tanious directly owns 0 shares of common stock.
- Tanious continues to hold 419,552 options from a June 12, 2019 grant and 580,709 options from a November 1, 2019 grant.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reflects routine transactions under a pre-arranged plan. There is no indication of positive or negative sentiment towards the company's prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like the President & COO, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects.
Comparison to Industry Standards
- Executive compensation packages often include stock options to align management's interests with those of shareholders.
- The use of 10b5-1 trading plans is a common practice among corporate executives to avoid accusations of insider trading, allowing them to sell shares at predetermined times and prices.
- Comparable companies in the retail sector also utilize similar compensation and trading strategies for their executives.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares by a key executive, but the pre-planned nature of the sale mitigates concerns.
Key Dates
| Date | Description |
|---|---|
| 09/15/2023 | Date the reporting person adopted the 10b5-1 Plan |
| 04/01/2024 | Date of option exercise and stock sale |
| 04/03/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.